Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18Colonic Neoplasms 7Rectal Neoplasms 5Neoplasm Metastasis 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Unresectable Metastatic Colorectal Cancer 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Prostatic Neoplasms 1Melanoma 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Gastroesophageal Adenocarcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

Oxaliplatin 1Folfox protocol 1Capecitabine 1ASTX-660 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Locally-advanced Rectal Cancer × Folfox protocol × Clear all
NCT05912075 2024-02-08

PRAAR1

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Recruiting
78 enrolled
Gastrointestinal

Locally-advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡